dr. martens plc - DRMTY
DRMTY
Close Chg Chg %
2.03 -0.20 -9.85%
Closed Market
1.83
-0.20 (9.85%)
Volume: 500.00
Last Updated:
Jun 3, 2026, 9:30 AM EDT
Company Overview: dr. martens plc - DRMTY
DRMTY Key Data
| Open $1.83 | Day Range 1.83 - 1.83 |
| 52 Week Range 1.43 - 2.60 | Market Cap $937.95M |
| Shares Outstanding 478.54M | Public Float N/A |
| Beta 0.98 | Rev. Per Employee N/A |
| P/E Ratio 29.68 | EPS N/A |
| Yield 292.97% | Dividend $0.02 |
| EX-DIVIDEND DATE Mar 6, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.05K |
DRMTY Performance
| 1 Week | 0.00% | ||
| 1 Month | 10.91% | ||
| 3 Months | 3.39% | ||
| 1 Year | 28.42% | ||
| 5 Years | N/A |
DRMTY Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
Full Ratings ➔
An error occurred while fetching the data.
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Dr. Martens Plc - DRMTY
Collapse All in section
| All values USD millions. | 2023 | 2024 | 2025 | 2026 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 1.20B | 1.10B | 1.00B | 1.03B | |
Sales Growth
| -2.94% | -8.51% | -8.80% | +2.02% | |
Cost of Goods Sold (COGS) incl D&A
| 525.32M | 470.00M | 444.70M | 439.01M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 65.24M | 90.81M | 92.74M | 92.06M | |
Depreciation
| 55.13M | 83.53M | 84.96M | 83.62M | |
Amortization of Intangibles
| 10.11M | 7.28M | 7.78M | 8.44M | |
COGS Growth
| +5.02% | -10.53% | -5.38% | -1.28% | |
Gross Income
| 678.80M | 631.65M | 560.02M | 586.02M | |
Gross Income Growth
| -8.33% | -6.95% | -11.34% | +4.64% | |
Gross Profit Margin
| +56.37% | +57.34% | +55.74% | +57.17% |
| 2023 | 2024 | 2025 | 2026 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 449.12M | 472.89M | 482.71M | 482.83M | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 449.12M | 472.89M | 482.71M | 482.83M | |
SGA Growth
| +6.27% | +5.29% | +2.08% | +0.02% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | 4.69M | 26.28M | 27.47M | |
EBIT after Unusual Expense
| 224.98M | 158.76M | 51.03M | 75.71M | |
Non Operating Income/Expense
| (10.59M) | (1.51M) | 765.40K | 5.23M | |
Non-Operating Interest Income
| 2.29M | 3.77M | 4.85M | 4.96M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 22.51M | 40.44M | 40.57M | 37.12M | |
Interest Expense Growth
| +9.87% | +79.67% | +0.30% | -8.49% | |
Gross Interest Expense
| 22.51M | 40.44M | 40.57M | 37.12M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 191.88M | 116.81M | 11.23M | 43.82M | |
Pretax Income Growth
| -34.45% | -39.12% | -90.39% | +290.35% | |
Pretax Margin
| +15.94% | +10.60% | +1.12% | +4.28% | |
Income Tax
| 36.71M | 29.89M | 5.49M | 11.93M | |
Income Tax - Current - Domestic
| 31.78M | 20.85M | 2.04M | 9.92M | |
Income Tax - Current - Foreign
| 5.18M | 8.04M | 4.85M | 4.29M | |
Income Tax - Deferred - Domestic
| (240.75K) | 1.00M | (1.40M) | (2.28M) | |
Income Tax - Deferred - Foreign
| - | - | - | - | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 155.16M | 86.92M | 5.74M | 31.89M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 155.16M | 86.92M | 5.74M | 31.89M | |
Net Income Growth
| -37.31% | -43.98% | -93.40% | +455.59% | |
Net Margin Growth
| +12.89% | +7.89% | +0.57% | +3.11% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 155.16M | 86.92M | 5.74M | 31.89M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 155.16M | 86.92M | 5.74M | 31.89M | |
EPS (Basic)
| 0.3102 | 0.1767 | 0.0119 | 0.0661 | |
EPS (Basic) Growth
| -37.32% | -43.04% | -93.27% | +455.46% | |
Basic Shares Outstanding
| 500.25M | 491.75M | 481.15M | 482.35M | |
EPS (Diluted)
| 0.31 | 0.1764 | 0.0118 | 0.0651 | |
EPS (Diluted) Growth
| -37.20% | -43.10% | -93.31% | +451.69% | |
Diluted Shares Outstanding
| 500.60M | 492.80M | 487.05M | 489.80M | |
EBITDA
| 294.92M | 249.57M | 170.05M | 195.25M | |
EBITDA Growth
| -19.85% | -15.38% | -31.86% | +14.82% | |
EBITDA Margin
| +24.49% | +22.65% | +16.92% | +19.05% |
An error occurred while fetching the data.
SEC Filings for Dr. Martens Plc - DRMTY
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
An error occurred while fetching the data.